Business
Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences
Jefferies Virtual Healthcare Conference on June 2, 2021 at 10:30 am ET Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 at 5:30 pm ET
About this update from Taysha Gene Therapies, Inc.
[{"type":"text","content":"\nJefferies Virtual Healthcare Conference on June 2, 2021 at 10:30 am ET\n\nGoldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 at 5:30 pm ET\n\nJMP Securities Life Science Conference on June 16, 2021 at 12:30 pm ET\n\n DALLAS--(BUSINESS WIRE)--\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivitol-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a virtual fireside chat for the Jefferies Virtual Healthcare Conference, Goldman Sachs 42nd Annual Global Healthcare Conference, and the JMP Securities Life Science Conference.\n\nConferences Details:\n\n\n\nEvent:\n\n\n\n\n\nJefferies Virtual Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n\n\nWednesday, June 2, 2021\n\n\n\n\n\nTime:\n\n\n\n\n\n10:30 am ET\n\n\n\n\n\nFormat:\n\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\nEvent:\n\n\n\n\n\nGoldman Sachs 42nd Annual Global Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n\n\nThursday, June 10, 2021\n\n\n\n\n\nTime:\n\n\n\n\n\n5:30 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n\n\n \n\n\n\nEvent:\n\n\n\n\n\nJMP Securities Life Science Conference\n\n\n\n\n\nDate:\n\n\n\n\n\nWednesday, June 16, 2021\n\n\n\n\n\nTime:\n\n\n\n\n\n12:30 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\nWebcasts for these conferences will be available in the “Events & Media” section of the Taysha corporate website at https://ir.tayshagtx.com/news-events/events-presentations. Archived versions of the webcasts will be available on the website for 6...